Trial Profile
Treatment of Leiomyomata With the Selective Progesterone Receptor Modulator CDB-2914
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- 14 Mar 2012 Additional lead trial investigator (Lynnette K Nieman) identified as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual patient number (57) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Jun 2007) added as reported by ClinicalTrials.gov.